Recent research underscores the critical need for improved patient care in managing endometrial hyperplasia, a condition characterized by the excessive thickening of the womb lining.
This condition is particularly concerning due to its potential to increase cancer risk among women.
Despite advancements in treatment following the introduction of national guidelines in 2016, a significant number of women still do not receive the necessary follow-up care to monitor and manage the condition effectively.
Endometrial hyperplasia is classified into two categories: atypical and non-atypical. The atypical form is associated with a higher risk of developing into cancer, while the non-atypical form indicates a thicker womb lining that is less likely to become cancerous.
In the UK, national guidance recommends a hysterectomy, the surgical removal of the womb, for those diagnosed with the more severe atypical hyperplasia.
For those with non-atypical hyperplasia, a trial of hormone treatment administered directly into the womb is advised, coupled with regular monitoring to detect any progression towards cancer.
A study conducted by researchers at the University of Edinburgh has shed light on treatment patterns both before and after these guidelines were established.
Analyzing anonymized patient records of over 3,000 UK women diagnosed with endometrial hyperplasia between 2012 and 2020, the study revealed significant findings.
Notably, the success rate of hormone treatment for non-atypical endometrial hyperplasia increased from 38% to 52% post-guideline implementation.
However, the rate of hysterectomy for atypical hyperplasia remained relatively unchanged, with a slight reduction observed at the onset of the COVID-19 pandemic in 2020, suggesting a departure from recommended practices.
Alarmingly, only 20% of women with atypical hyperplasia who did not undergo a hysterectomy received the advised follow-up monitoring and biopsies.
Among those who had a hysterectomy for atypical hyperplasia, 37% were found to have cancer upon post-surgical analysis of their wombs, highlighting the critical nature of this condition.
These findings emphasize the necessity of improved follow-up care for women with endometrial hyperplasia, especially those with the atypical form who opt out of hysterectomy.
The study’s insights call for a concerted effort to ensure these women receive the comprehensive monitoring and management needed to mitigate their heightened risk of developing cancer.
Dr. Michael Rimmer, reflecting on the study’s outcomes, stresses the importance of enhancing care for these women, pointing to the significant implications for their future health and well-being.
If you care about cancer risk, please read studies that exercise may stop cancer in its tracks, and vitamin D can cut cancer death risk.
For more information about cancer, please see recent studies that yogurt and high-fiber diet may cut lung cancer risk, and results showing that new cancer treatment may reawaken the immune system.
The research findings can be found in PLOS Medicine.
Copyright © 2024 Knowridge Science Report. All rights reserved.